CEN/TC 206
Registration number (WIID) | Project No. | Title | Status |
---|---|---|---|
74131 | EN ISO 10993-18:2020/A1:2023 | Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process - Amendment 1: Determination of the uncertainty factor (ISO 10993-18:2020/Amd 1:2022) | Standarts spēkā |
9484 | EN ISO 10993-2:1998 | Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:1992) | Atcelts |
22132 | EN ISO 10993-2:2006 | Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:2006) | Atcelts |
69998 | EN ISO 10993-2:2022 | Biological evaluation of medical devices - Part 2: Animal welfare requirements (ISO 10993-2:2022) | Standarts spēkā |
68925 | EN ISO 10993-23:2021 | Biological evaluation of medical devices - Part 23: Tests for irritation (ISO 10993-23:2021) | Standarts spēkā |
78993 | EN ISO 10993-23:2021/prA1 | Biological evaluation of medical devices - Part 23: Tests for irritation - Amendment 1: Additional in vitro reconstructed human epidermis models (ISO 10993-23:2021/DAmd1:2024) | Izstrādē |
9495 | EN ISO 10993-3:2003 | Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity (ISO 10993-3:2003) | Atcelts |
31978 | EN ISO 10993-3:2009 | Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity (ISO 10993-3:2003) | Atcelts |
30398 | EN ISO 10993-3:2014 | Biological evaluation of medical devices - Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity (ISO/DIS 10993-3:2011) | Standarts spēkā |
9496 | EN ISO 10993-4:2002 | Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood (ISO 10993-4:2002) | Atcelts |
Displaying 51-60 of 190 results.